Tiziana Life Sciences (TLSA) Operating Leases (2019 - 2025)

Tiziana Life Sciences has reported Operating Leases for 7 years, with the latest figure at $234000.0 in Q4 2025.

• On a quarterly basis, Operating Leases rose 120.75% year-over-year to $234000.0 in Q4 2025; TTM through Dec 2025 was $234000.0, a 120.75% increase from a year earlier, with the FY2025 full-year figure at $234000.0, up 120.75% from the prior year.
• Operating Leases was $234000.0 for Q4 2025 at Tiziana Life Sciences, up from $107000.0 in the prior quarter.
• The five-year high for Operating Leases was $243000.0 in Q4 2022, with the low at $106000.0 in Q4 2024.
• Average Operating Leases over 5 years is $171500.0, with a median of $156000.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Leases plunged 43.21% in 2023, then jumped 120.75% in 2025.
• Over 5 years, Operating Leases stood at $232000.0 in 2021, then advanced by 4.74% to $243000.0 in 2022, then slumped by 43.21% to $138000.0 in 2023, then dropped by 23.19% to $106000.0 in 2024, then jumped by 120.75% to $234000.0 in 2025.
• The last three Operating Leases figures came in at $234000.0 (Q4 2025), $107000.0 (Q2 2025), and $106000.0 (Q4 2024), per Business Quant data.